您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Vazegepant hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Vazegepant hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Vazegepant hydrochloride图片
CAS NO:1414976-20-7
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
25mg电议
50mg电议

产品介绍
Vazegepant (BHV-3500) hydrochloride 是一种高度亲和性 CGRP 受体拮抗剂 (hCGRP Ki=0.023 nM)。Vazegepant hydrochloride 是第一种用于偏头痛的鼻用 gepant。Vazegepant hydrochloride 可能有助于有效管理 COVID-19 相关肺部炎症。
Cas No.1414976-20-7
别名Zavegepant hydrochloride; BHV-3500 hydrochloride
分子式C36H47ClN8O3
分子量675.26
溶解度Water : 50 mg/mL (74.05 mM; Need ultrasonic)|DMSO : 50 mg/mL (74.05 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Vazegepant (BHV-3500) hydrochloride is a highly affinity CGRP receptor antagonist (hCGRP Ki= 0.023 nM). Vazegepant hydrochloride is the first intranasal gepant for migraine. Vazegepant hydrochloride may be helpful in effective management of COVID-19 associated pulmonary inflammation[1][2][3].

[1]. Moreno-Ajona D, et al. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment•. Curr Opin Neurol. 2020;33(3):309-315.
[2]. Mehta PP, et al. Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications. Am J Med Sci. 2021;361(5):557-566.
[3]. Moreno-Ajona D, PÉrez-RodrÍguez A, Goadsby PJ. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment•. Curr Opin Neurol. 2020;33(3):309-315.